HK1254547A1 - 抗病毒劑和治療病毒感染的方法 - Google Patents
抗病毒劑和治療病毒感染的方法Info
- Publication number
- HK1254547A1 HK1254547A1 HK18113840.5A HK18113840A HK1254547A1 HK 1254547 A1 HK1254547 A1 HK 1254547A1 HK 18113840 A HK18113840 A HK 18113840A HK 1254547 A1 HK1254547 A1 HK 1254547A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- treatment
- viral infection
- virus agent
- virus
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Physiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- AIDS & HIV (AREA)
- Nutrition Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2016900595A AU2016900595A0 (en) | 2016-02-19 | Method for treatment of cancer or viral infection | |
AU2016902715A AU2016902715A0 (en) | 2016-07-11 | Method for treatment of cancer or viral infection | |
PCT/AU2017/050139 WO2017139849A1 (en) | 2016-02-19 | 2017-02-17 | Anti-virus agent and method for treatment of viral infection |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1254547A1 true HK1254547A1 (zh) | 2019-07-19 |
Family
ID=59624666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18113840.5A HK1254547A1 (zh) | 2016-02-19 | 2018-10-30 | 抗病毒劑和治療病毒感染的方法 |
Country Status (8)
Country | Link |
---|---|
US (2) | US11045491B2 (zh) |
EP (1) | EP3416656B1 (zh) |
JP (1) | JP6812436B2 (zh) |
CN (1) | CN108472311B (zh) |
AU (2) | AU2017220391B2 (zh) |
ES (1) | ES2867453T3 (zh) |
HK (1) | HK1254547A1 (zh) |
WO (1) | WO2017139849A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021151160A1 (en) * | 2020-01-31 | 2021-08-05 | Recce Pharmaceuticals Ltd | Process for preparation of biologically active copolymer |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0076636B1 (en) * | 1981-09-30 | 1988-02-24 | National Research Development Corporation | Sustained release compositions |
NZ222979A (en) * | 1986-12-23 | 1990-09-26 | Biopolymers Ltd | Polymeric biocidal or biostatic compounds and compositions |
CN87108390A (zh) * | 1986-12-23 | 1988-09-21 | 生物聚合物有限公司 | 抑制生物和杀生物的组合物 |
AUPN327695A0 (en) | 1995-05-30 | 1995-06-22 | Chemeq Pty. Limited | Chemotherapeutic compositions |
US6060571A (en) | 1996-02-22 | 2000-05-09 | Degussa Aktiengesellschaft | Acrolein-releasing copolymers |
ATE201218T1 (de) * | 1996-02-22 | 2001-06-15 | Degussa | Acrolein freisetzende copolymere |
US6060235A (en) | 1997-09-19 | 2000-05-09 | Geltex Pharmaceuticals, Inc. | Antiviral polymers comprising acid functional groups and hydrophobic groups |
US7629002B2 (en) | 2000-02-16 | 2009-12-08 | Chemeq Ltd. | Antimicrobial polymeric compositions and method of treatment using them |
DK1274749T3 (da) | 2000-02-16 | 2008-09-15 | Chemeq Ltd | Antimikrobielle polymeriske sammensætninger |
AUPS327102A0 (en) * | 2002-06-28 | 2002-07-18 | Chemeq Ltd | Method of treatment or prophylaxis of gastrointestinal diseases |
CN1617733B (zh) * | 2002-01-18 | 2010-04-07 | 凯米克有限公司 | 胃肠疾病的治疗方法和用于其中的聚合物组合物 |
JP4680926B2 (ja) * | 2003-11-06 | 2011-05-11 | ケメック・リミテッド | ポリアクロレインの製造方法 |
WO2009059350A1 (en) | 2007-11-07 | 2009-05-14 | Recce Pty Ltd | Anti-microbial polymers and their compositions |
EP2186521A1 (en) | 2008-11-14 | 2010-05-19 | Mergemeier Steffen | Compositons for the treatment and prevention of diseases involving bacterial, viral and fungal pathogens and fragments thereof with polyvinylpyrrolidone and/or polyvinylpolypyrrolidone as therapeutically active compound |
WO2011047420A1 (en) * | 2009-10-19 | 2011-04-28 | Chemeq Ltd | Cosmetic compositions |
AU2010100972A4 (en) * | 2009-10-19 | 2010-10-07 | Chemeq Ltd | Topical antimicrobial compositions |
US20190202908A1 (en) * | 2014-04-15 | 2019-07-04 | President And Fellows Of Harvard College | Bi-specific agents |
ES2755474T3 (es) | 2014-11-18 | 2020-04-22 | Recce Pharmaceuticals Ltd | Copolímero y método para el tratamiento de infecciones bacterianas |
-
2017
- 2017-02-17 AU AU2017220391A patent/AU2017220391B2/en active Active
- 2017-02-17 JP JP2018528557A patent/JP6812436B2/ja active Active
- 2017-02-17 EP EP17752574.8A patent/EP3416656B1/en active Active
- 2017-02-17 CN CN201780005078.4A patent/CN108472311B/zh active Active
- 2017-02-17 US US15/771,858 patent/US11045491B2/en active Active
- 2017-02-17 ES ES17752574T patent/ES2867453T3/es active Active
- 2017-02-17 WO PCT/AU2017/050139 patent/WO2017139849A1/en active Application Filing
-
2018
- 2018-10-30 HK HK18113840.5A patent/HK1254547A1/zh unknown
-
2021
- 2021-05-21 US US17/326,995 patent/US20210275573A1/en active Pending
-
2023
- 2023-03-28 AU AU2023201883A patent/AU2023201883A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN108472311A (zh) | 2018-08-31 |
US20180338994A1 (en) | 2018-11-29 |
JP6812436B2 (ja) | 2021-01-13 |
US11045491B2 (en) | 2021-06-29 |
AU2017220391A1 (en) | 2018-05-17 |
CN108472311B (zh) | 2021-06-22 |
EP3416656B1 (en) | 2021-04-21 |
ES2867453T3 (es) | 2021-10-20 |
AU2017220391B2 (en) | 2023-01-19 |
WO2017139849A1 (en) | 2017-08-24 |
EP3416656A1 (en) | 2018-12-26 |
JP2019510731A (ja) | 2019-04-18 |
US20210275573A1 (en) | 2021-09-09 |
EP3416656A4 (en) | 2019-11-13 |
AU2023201883A1 (en) | 2023-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL257384A (en) | Preparations containing rnai and their use for the treatment of infection with the hepatitis b virus | |
HK1251554A1 (zh) | 用於治療和預防病毒感染的新的取代的氨基噻唑並嘧啶二酮 | |
HK1248711A1 (zh) | 用於治療和預防病毒感染的新的取代的氨基噻唑並嘧啶二酮 | |
HRP20190352T1 (hr) | Novi 6-kondenzirani heteroarildihidropirimidini za liječenje i profilaksu infekcije virusom hepatitisa b | |
HK1223931A1 (zh) | 用於治療和預防乙型肝炎病毒感染的新型二氫喹嗪酮類化合物 | |
HK1231402A1 (zh) | 治療 型肝炎和 型肝炎病毒感染的方法 | |
IL263368A (en) | Prevention and treatment of viral infections | |
EP3512524A4 (en) | METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS | |
HK1252343A1 (zh) | 用於治療病毒感染的組合物和方法 | |
HK1251010A1 (zh) | 用於治療乙型肝炎病毒(hbv)感染的試劑及用途 | |
ZA201902385B (en) | Compounds and methods for diagnosis and treatment of viral infections | |
PL3137078T3 (pl) | Leczenie zakażenia wirusem zapalenia wątroby typu delta | |
HUE054191T2 (hu) | A hepatitis delta vírusfertõzés kezelése | |
PL3183003T3 (pl) | SPOSOBY ZAPOBIEGANIA l/LUB LECZENIA ZAKAŻENIA | |
EP3226973A4 (en) | Treatment of hepatitis delta virus infection | |
EP3538108A4 (en) | METHOD FOR TREATING OR INHIBITIONING AN EBOLA VIRUS INFECTION | |
HK1254547A1 (zh) | 抗病毒劑和治療病毒感染的方法 | |
EP3574089A4 (en) | ANTIVIRAL AGENT AND METHOD OF TREATMENT OF A VIRAL INFECTION | |
GB201615035D0 (en) | Treatment and prevention of viral infection | |
GB201615550D0 (en) | Detection and treatment of microsporidian infection | |
EP3426659A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF ZIKA VIRUS INFECTION | |
IL286484B (en) | Reagents for treatment of hepatitis b virus (hbv) infection and use thereof | |
GB201608348D0 (en) | Apparatus for and method of treating viral infections | |
GB201608355D0 (en) | Apparatus for and method of treating viral infections | |
GB201608352D0 (en) | Apparatus for and method of treating viral infections |